The IP Solutions business of Thomson Reuters has announced a strategic partnership with ChemAxon, a provider of cheminformatics software development platforms and applications for the life sciences industry. Under the deal, Thomson Reuters will provide its chemical IP Data Feeds - Markush Structures and patent data to users of ChemAxon's JChem chemical software platform. It is expected that this search and analysis solution will speed drug discovery and allow life science researchers to easily integrate critical content into their existing systems and workflow.
The Markush structures from Thomson Reuters are part of the company's Derwent World Patents Index (DWPISM) database, claimed to be the world's most trusted and authoritative source of global patent information. The Markush database contains essential data on the relationship or 'families' of 550,000 patents, making it the world's leading source for life sciences patentability research, competitive intelligence and IP screening.
ChemAxon's JChem software allows life science professionals to structure and visualise chemical compounds for property prediction, virtual synthesis, screening and drug design. Through this partnership R&D end users can now research and analyse Markush structures using ChemAxon's JChem chemical software platform. The ability to quickly retrieve this information will now allow R&D end users to save time and capitalise on R&D investment.
Search for more Patent Information
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
